Saturday, January 29, 2022


New data shows GSK-Vir drug works against all Omicron mutations

The data, yet to be published in a peer-reviewed medical journal, shows that the companies' treatment, sotrovimab, is effective against all 37 identified mutations to date in the spike protein, according to GSK.

5 questions about new Covid mutations

Whether current vaccines will still work, and what can be done about the mutations are some of the questions currently swirling.

Other News